Neurothera Labs Inc. operates a clinical-stage pharmaceutical company. The company engages in the drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzhe…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-27 M&A
NEUROTHERA LABS INC. PROVIDES UPDATE ON PROPOSED ACQUISITION OF MAJORITY STAKE IN CLINIQUANTUM LTD.
News release - English.pdf
Transactions 2026-04-30 M&A
Neurothera Labs Announces Continuance into Ontario
News release - English.pdf
Ownership 2026-04-30
Other securityholders documents - English.pdf
Ownership 2026-04-30
Other securityholders documents - English.pdf
Results 2026-04-29
Annual MD&A - English.pdf
Results 2026-04-29
Audited annual financial statements – English.pdf
News 2026-04-23
Neurothera Labs Engages bullVestor for Investor Relations Activities
News release - English.pdf
Ownership 2026-04-03
Other securityholders documents - English.pdf
News 2026-03-19
Other securityholders documents - English.pdf
Transactions 2026-03-19 M&A
NeuroThera Labs Inc. Enters into Definitive Share Purchase Agreement to Acquire CliniQuantum Ltd.
Material change report - English.pdf
News 2026-03-17
Other.pdf
News 2026-03-16
NeuroThera Labs and Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
News release - English.pdf
News 2026-03-11
NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
News release - English.pdf
Transactions 2026-03-10 M&A
NEUROTHERA LABS INC. ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE MAJORITY STAKE IN CLINIQUANTUM LTD.
News release - English.pdf
News 2026-02-02
Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
News release - English.pdf
News 2026-01-22
Letter from former auditor.pdf
News 2026-01-22
Letter from successor auditor.pdf
News 2026-01-22
Notice.pdf
News 2025-12-30
Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
News release - English.pdf
News 2025-12-15
Other.pdf
Transactions 2025-12-02 M&A
Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
News release - English.pdf
Results 2025-11-20 Financials
Financial statements of RTO acquirer.pdf
Results 2025-11-20 Financials
Financial statements of RTO acquirer.pdf
News 2025-11-19
Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
News release - English.pdf
News 2025-11-06
Notice (amended).pdf
News 2025-10-30
Report of exempt distribution (45-106F1).pdf
News 2025-10-30
Material change report - English.pdf
News 2025-10-30
Notice.pdf
News 2025-10-22
Early warning report.pdf
News 2025-10-22
Press release - English.pdf
News 2025-10-22
News release - English.pdf
News 2025-10-22
Certificate and articles of change of name.pdf
News 2025-10-20
News release - English.pdf
News 2025-10-10
News release - English.pdf
News 2025-10-10
Material change report - English.pdf
News 2025-10-10
News release - English.pdf
News 2025-10-09
Filing statement - English.pdf
Results 2025-09-29 Financials
Interim MD&A - English.pdf
Results 2025-09-29 Financials
Interim financial statements/report – English.pdf
News 2025-07-31
News release - English.pdf
Results 2025-06-26 Financials
Interim MD&A - English.pdf
Results 2025-06-26 Financials
Interim financial statements/report – English.pdf